Skip to main content
Clinical Trials/NCT03988075
NCT03988075CompletedNot Applicable

Use of Enhanced Recovery After Surgery (ERAS) in Minimizing Opioid Use for Patients Undergoing Thyroidectomy

Medstar Health Research Institute2 sites in 1 country100 target enrollmentStarted: July 24, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100
Locations
2
Primary Endpoint
visual analog scale pain level

Study Overview

Brief Summary

Pain control modalities were evaluated after thyroidectomy.

Detailed Description

Pain control modalities were evaluated after thyroidectomy. Patients were randomized to one of two pain control regimens. The control group received conventional opioid based post operative analgesia while the test group received an enhanced recovery after surgery (ERAS) based anesthesia with use of acetaminophen and non-steroidal anti-inflammatory drugs for the post operative period with opioid medications available for break through pain only. Pain scores (measured on visual analog scale) and opioid use (measured in morphine equivalent dose) were measured after completion of the operation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • thyroid disease

Exclusion Criteria

  • currently on opioid pain medications
  • on opioid pain meds in last 30 days
  • cannot take non-opioid medications
  • require more extensive operation than thyroidectomy

Outcomes

Primary Outcomes

visual analog scale pain level

Time Frame: 7 days post operatively

Pain level from 0 (no pain) to 10 (worst pain imaginable).

Secondary Outcomes

  • opioid use(with the first 24 hours post operatively)

Investigators

Sponsor
Medstar Health Research Institute
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials